Glass House Brands Inc. Faces Financial Challenges Amid Expansion

Font: Financial Modeling Prep  • Mar 25, 2026

• Glass House Brands Inc. (OTC:GLASF) reported an EPS of -$0.20, missing estimates and highlighting profitability struggles.
• The company's revenue was $38.86 million, below expectations, but it remains optimistic about future production capabilities.
• Despite financial challenges, Glass House Brands has a current ratio of 2.24 and projects significant growth in cash balance and production capacity.

Glass House Brands Inc. (OTC:GLASF) is a vertically integrated cannabis company in the U.S., focusing on cultivation, manufacturing, and distribution. Despite its rapid expansion, the company faces financial challenges, competing with industry giants like Canopy Growth and Aurora Cannabis.

On March 24, 2026, GLASF reported an earnings per share (EPS) of -$0.20, missing the estimated EPS of -$0.15. This reflects the company's ongoing struggle with profitability, as highlighted by its negative price-to-earnings (P/E) ratio of approximately -415.12. The negative earnings yield of -0.24% further underscores this issue.

The company generated a revenue of approximately $38.86 million, falling short of the estimated $45.8 million. Despite this, Glass House Brands is optimistic about its future production capabilities. For 2026, the company forecasts its wholesale cannabis biomass production to reach about one million pounds, a 50% increase from 2025.

Glass House Brands ended 2025 with a cash and restricted cash balance of $23.4 million. The company projects this to exceed $50 million by the end of 2026. This projection is supported by a current ratio of approximately 2.24, indicating strong short-term financial health.

The company's debt-to-equity ratio is about 0.93, suggesting a moderate level of debt relative to equity. This balance is crucial as Glass House Brands continues to expand its operations and increase its production capacity. The enterprise value to sales ratio of approximately 3.24 reflects the company's valuation relative to its sales.